# Effectiveness of Mucolox® and Clonazepam in Treatment of Burning Mouth Syndrome

> **NCT02690844** · PHASE4 · WITHDRAWN · sponsor: **University of Alberta**

## Conditions studied

- Burning Mouth Syndrome

## Interventions

- **DRUG:** Clonazepam mixed with Mucolox®
- **DRUG:** Mucolox® alone
- **DRUG:** Clonazepam

## Key facts

- **NCT ID:** NCT02690844
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-04
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2018-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02690844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02690844, "Effectiveness of Mucolox® and Clonazepam in Treatment of Burning Mouth Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02690844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*